Procaps Group Announces Termination of Acquisition Agreement with Grupo Somar
January 03, 2023 16:13 ET
|
Procaps Group, S.A.
MIAMI and BARRANQUILLA, Colombia, Jan. 03, 2023 (GLOBE NEWSWIRE) -- Procaps Group, S.A. (NASDAQ: PROC) (“Procaps” or the “Company”), a leading integrated LatAm healthcare and pharmaceutical...
Procaps to Present at 2023 Annual J.P. Morgan Healthcare Conference
December 29, 2022 08:00 ET
|
Procaps Group, S.A.
MIAMI and BARRANQUILLA, Colombia, Dec. 29, 2022 (GLOBE NEWSWIRE) -- Procaps Group, S.A. (NASDAQ: PROC) (“Procaps” or the “Company”), a leading integrated LatAm healthcare and pharmaceutical...
Update on Proposed Acquisition of Grupo Somar
December 22, 2022 16:02 ET
|
Procaps Group, S.A.
MIAMI and BARRANQUILLA, Colo., Dec. 22, 2022 (GLOBE NEWSWIRE) -- Procaps Group, S.A. (NASDAQ: PROC) (“Procaps” or the “Company”), a leading integrated LatAm healthcare and pharmaceutical...
Procaps Group Reports Third Quarter and Nine Months 2022 Results
November 14, 2022 17:32 ET
|
Procaps Group, S.A.
MIAMI and BARRANQUILLA, Colombia, Nov. 14, 2022 (GLOBE NEWSWIRE) -- Procaps Group S.A. (NASDAQ: PROC) (“Procaps”), a leading integrated LatAm healthcare and pharmaceutical conglomerate, today...
Procaps Group to Report Third Quarter and Nine Months of 2022 on November 14, 2022
November 08, 2022 15:36 ET
|
Procaps Group, S.A.
MIAMI and BARRANQUILLA, Colombia, Nov. 08, 2022 (GLOBE NEWSWIRE) -- Procaps Group (NASDAQ: PROC) (“Procaps”), a leading integrated LatAm healthcare and pharmaceutical conglomerate, announced that it...
Procaps Announces ESG Commitments and Initiatives with Inaugural Report
October 11, 2022 08:00 ET
|
Procaps Group, S.A.
MIAMI and BARRANQUILLA, Colombia, Oct. 11, 2022 (GLOBE NEWSWIRE) -- Procaps Group (NASDAQ: PROC) (“Procaps”), a leading integrated LatAm healthcare and pharmaceutical conglomerate, today announced...
Procaps Group to Participate in the BTG Pactual LatAm CEO Conference
October 05, 2022 10:15 ET
|
Procaps Group, S.A.
MIAMI and BARRANQUILLA, Colombia, Oct. 05, 2022 (GLOBE NEWSWIRE) -- Procaps Group (NASDAQ: PROC) (“Procaps”), a leading integrated LatAm healthcare and pharmaceutical conglomerate, today announced...
Procaps Group Reports Second Quarter and First Half 2022 Results
August 30, 2022 06:40 ET
|
Procaps Group, S.A.
Net Revenues Increased 14% year-over-year in the Second Quarter, with Adjusted EBITDA Margin of 24%Constant currency Net Revenues Increased by 18% year-over-year in the First Half, signaling a strong...
Procaps Group Reports Preliminary First Quarter 2022 Results
June 02, 2022 08:14 ET
|
Procaps Group, S.A.
MIAMI and BARRANQUILLA, Colombia, June 02, 2022 (GLOBE NEWSWIRE) -- Procaps Group S.A. (NASDAQ: PROC) (“Procaps”), a leading integrated LatAm healthcare and pharmaceutical conglomerate, today...
Grupo Procaps adquirirá Grupo Somar (incluyendo Química y Farmacia, Gelcaps y entidades relacionadas) de Advent International, ganando una importante presencia en México, el segundo mercado más grande de la región
May 17, 2022 23:01 ET
|
Procaps Group, S.A.
Esta adquisición reafirma la estrategia de Procaps Group de convertirse en una de las organizaciones farmacéuticas de más rápido crecimiento en América Latina.Con ingresos netos de $184 millones en el...